CDC: New Vancomycin-resistant Strep Strains Have Appeared

The Centers for Disease Control and Prevention as well as physicians in New York and New Mexico have confirmed two cases of vancomycin-resistant group B Streptococcus infections, according to a research letter in the New England Journal of Medicine.

Advertisement

The cases involved unrelated strains of bacteria that had independently acquired vancomycin-resistance genes and were also resistant to other classes of antibiotics.

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!

Strep B most commonly causes meningitis and bloodstream infections but can also cause joint and skin infections, according to a report from HealthDay.

More Articles on Infection Control & Clinical Quality:

10 Most-Read Patient Safety Tools Feb. 24-28

Study: Not Reporting Lab Tests to Physicians May Help Cut Unnecessary Antibiotic Use

Increasing Nurse Workload by One Patient Increases Patient Mortality by 7%

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.